Amicus Therapeutics Common
(FOLD)
|
17.6 |
$46M |
|
4.2M |
10.88 |
Lion Biotechnologies Common
|
10.0 |
$26M |
|
2.1M |
12.11 |
Sorrento Therapeutics Common
(SRNE)
|
9.8 |
$26M |
|
2.2M |
11.56 |
Celgene Corp. Common
|
6.6 |
$17M |
|
149k |
115.28 |
Pernix Therapeutics Holdings Common
|
5.7 |
$15M |
|
1.4M |
10.69 |
Bellicum Pharmaceuticals Common
|
4.2 |
$11M |
|
475k |
23.17 |
Agenus - Common
|
4.0 |
$11M |
|
2.0M |
5.13 |
Emergent Biosolutions Common
(EBS)
|
3.6 |
$9.5M |
|
331k |
28.76 |
Mirati Therapeutics Common
|
3.6 |
$9.4M |
|
321k |
29.32 |
La Jolla Pharmaceutical Common
|
3.2 |
$8.4M |
|
462k |
18.30 |
Taro Pharmaceutical Indus Shares
(TARO)
|
2.9 |
$7.6M |
|
54k |
141.02 |
Oncothyreon Common
|
2.8 |
$7.3M |
|
4.5M |
1.63 |
Receptos Common
|
2.8 |
$7.3M |
|
44k |
164.89 |
Stemline Therapeutics - Common
|
2.6 |
$6.9M |
|
475k |
14.47 |
Igi Laboratories Common
|
2.3 |
$5.9M |
|
721k |
8.16 |
Uniqure N V Common
(QURE)
|
2.1 |
$5.5M |
|
227k |
24.32 |
Tonix Pharmaceuticals Hldg Common
|
1.8 |
$4.8M |
|
755k |
6.32 |
Vericel Corp. Common
(VCEL)
|
1.5 |
$3.9M |
|
1.1M |
3.70 |
Flamel Technologies Sponsored ADR
|
1.5 |
$3.9M |
|
216k |
17.98 |
Sangamo Biosciences Common
(SGMO)
|
1.5 |
$3.8M |
|
244k |
15.68 |
Trillium Therapeutics Common
|
1.2 |
$3.2M |
|
161k |
20.12 |
Exelixis Inc Exel 20190815 4.250000% Notes (Principal)
|
1.2 |
$3.2M |
|
4.3M |
0.76 |
Chemocentryx - Common
|
0.9 |
$2.4M |
|
324k |
7.55 |
Therapeutics Md Common
|
0.9 |
$2.4M |
|
392k |
6.05 |
Coronado Biosciences Common
|
0.9 |
$2.3M |
|
600k |
3.85 |
Trovagene Common
|
0.8 |
$2.2M |
|
324k |
6.81 |
Ignyta Common
|
0.8 |
$2.0M |
|
201k |
9.95 |
Innocoll Sponsored ADR
|
0.6 |
$1.7M |
|
225k |
7.51 |
Heat Biologics Common
|
0.6 |
$1.7M |
|
260k |
6.36 |
Biolase Common
|
0.5 |
$1.4M |
|
690k |
2.02 |
Targacept Common
|
0.5 |
$1.4M |
|
466k |
2.97 |
Cellectis Sponsored ADS
(CLLS)
|
0.4 |
$1.0M |
|
30k |
34.57 |
Alimera Sciences Common
|
0.2 |
$408k |
|
81k |
5.01 |